Buy Tesamorelin 10mg / Ipamorelin 2mg Blend at Loti Labs

Molecular Reference Data

The Dual Mechanism — Why Researchers Use the Blend

Here’s where the two pathways converge in interesting ways. Tesamorelin binds GHRH receptors on anterior pituitary somatotrophs, triggering adenylyl cyclase activation, cyclic AMP elevation, and ultimately pulsatile GH secretion — all while preserving the physiological somatostatin feedback loop. That feedback preservation is significant. It means researchers studying naturalistic GH regulation get data that reflects actual biological dynamics rather than an artificially uncapped signal.

Ipamorelin hits a different cell surface receptor entirely. Via GHSR-1a activation, it drives GH secretion through phospholipase C and intracellular calcium — an independent signaling arm. The net effect when both compounds are present is additive stimulation across two distinct receptor populations. Research comparing single-compound and combination protocols has consistently found that blended administration generates greater GH output than either compound alone. That’s not a surprise mechanistically — what’s useful is that the margin of enhancement is significant enough to be measurable and interpretable in experimental models.

elated Compounds at Loti Labs

Researchers designing GH axis investigations have several options depending on their protocol needs. The CJC-1295 (no DAC) / Ipamorelin 5mg blend offers an alternative GHRH pairing with ipamorelin — useful for comparative receptor studies. For oral GH secretagogue research, MK-677 is available as a separate compound. The full peptide research catalog at Loti Labs covers a wide range of endocrine and metabolic research applications.

Storage and Reconstitution

The blend ships as a co-lyophilized white powder. Store at room temperature, away from light and moisture, until you’re ready to reconstitute. Bacteriostatic or sterile water both work depending on your experimental timeline and planned storage duration post-reconstitution. Avoid repeated freeze-thaw cycles once the solution is prepared. Standard peptide lab procedures and institutional safety protocols apply throughout all research activities involving this compound.

Why Source from Loti Labs

Blended peptide compounds have an added quality challenge — both active components have to meet purity specs, and the ratio has to be consistent batch to batch. Loti Labs independently tests every batch via HPLC, and a batch-specific Certificate of Analysis ships with every order. The 10mg tesamorelin / 2mg ipamorelin ratio reflects the proportions most commonly referenced in published research protocols. Same-day shipping on orders placed before 1pm ET, Monday through Friday, in temperature-controlled packaging. A 30-day satisfaction guarantee covers all purchases.

Research Use Only

The Tesamorelin 10mg / Ipamorelin 2mg blend from Loti Labs is strictly for in-vitro laboratory research by qualified professionals. Neither compound in this blend carries approval for human or veterinary use. This is not a supplement, food, or medical product of any kind. Compliance with applicable research chemical regulations in your jurisdiction is the researcher’s responsibility. Institutional documentation, oversight, and safety protocols apply to all experimental use of this compound.

Loti Labs Shipping

Same-day shipping on orders placed before 1pm ET, Monday through Friday. Weekend and after-hours orders ship the next business day, in temperature-controlled packaging to preserve lyophilized integrity during transit.

Third-Party Verified — COA with Every Order

Independent HPLC testing on every production batch. Purity, identity, and quantity are all verified before shipment. A batch-specific Certificate of Analysis is included with every order as standard practice.

References

• Falutz J, et al. (2007). “Metabolic effects of a growth hormone-releasing factor in patients with HIV.” New England Journal of Medicine, 357(23), 2349-2360.
• Stanley TL, et al. (2014). “Effects of tesamorelin on non-alcoholic fatty liver disease in HIV-infected patients with abdominal fat accumulation.” Clinical Infectious Diseases, 58(2), 283-290.
• Friedman SD, et al. (2013). “Growth hormone releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging.” JAMA Neurology, 70(7), 883-890.
• Raun K, et al. (1998). “Ipamorelin, the first selective growth hormone secretagogue.” European Journal of Endocrinology, 139, 552-561.